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Abstract In this study, we present the multiple detection of
respiratory viruses in infants during primary respiratory
illness, investigate the sensitivity of nasal swabs and
nasopharyngeal aspirates, and assess whether patient charac-
teristics and viral load played a role in the sensitivity.
Healthy infants were included at signs of first respiratory
tract infection. Paired nasopharyngeal aspirates and nasal
swabs were collected. Real-time polymerase chain reaction
(PCR) was carried out for 11 respiratory pathogens. Paired
nasopharyngeal aspirates and nasal swabs were collected in
98 infants. Rhinovirus (n=67) and respiratory syncytial virus
(n=39) were the most frequently detected. Co-infection
occurred in 48% (n=45) of the infants. The sensitivity of
the nasal swab was lower than the nasopharyngeal aspirate,
in particular, for respiratory syncytial virus (51% vs. 100%)
and rhinovirus (75% vs. 97%). The sensitivity of the nasal
swab was strongly determined by the cycle threshold (CT)
value (p<0.001). The sensitivity of the swab for respiratory
syncytial virus, but not rhinovirus, was 100% in children
with severe symptoms (score ≥11). It is concluded that, for
community-based studies and surveillance purposes, the
nasal swab can be used, though the sensitivity is lower than
the aspirate, in particular, for the detection of mild cases of
respiratory syncytial virus (RSV) infection.
Abbreviations
NS Nasal swab
NPA Nasopharyngeal aspirate
PCR Polymerase chain reaction
hMPV Human metapneumovirus
RSV Respiratory syncytial virus
Background
Respiratory viruses are a common cause of illness in
children, in particular during their first years of life, and
may lead to more severe morbidity and hospitalisation
[1–4]. Different types of specimen are available for viral
diagnosis. The nasopharyngeal aspirate (NPA) has been
considered to be the best sampling technique, but is more
invasive and results in significantly more distress of the
infant than a nasal swab (NS) [5]. A number of studies have
compared the sensitivity of the NPA with nasopharyngeal
swabs [6], nose–throat swabs [7] and NS [5, 8–10].
Generally, conventional techniques such as viral culture
and antigen detection methods were used. The use of real-
time polymerase chain reaction (PCR) may overcome
differences in sensitivity for respiratory viruses as a result
of specimen type [7].
Limited data are available on the comparison of these
sampling methods combined with real-time PCR. It was
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observed that nose–throat swabs are a less invasive
diagnostic technique, with adequate sensitivity for use in
outpatient and large community-based settings in children
[7]. However, no tests were performed for rhinovirus, even
though this virus commonly infects infants [11]. The aim of
this study was to present the detection of common
respiratory pathogens in infants during primary respiratory
illness, to investigate the sensitivity of the NS and NPA,
and assess the role of patient characteristics and viral load
in the sensitivity of either sampling method.
Study design
Study cohort
The study is part of the Netherlands Amnion Fluid Study of
the Utrecht University Medical Centre (UUMC), the
Netherlands [12]. Healthy infants were included at birth
and were at risk for primary respiratory infection until the
age of one year. The data collection and episode sampling
stopped one year after birth. From April 2006 to April
2008, including two winter seasons, paired NPA and NS
specimens were obtained from 98 infants. Parents were
instructed to notify the clinical staff within 24 h after the
onset of symptoms. Clinical staff visited the child within
36 h and the history of illness was taken by a standardised
questionnaire. Symptoms were scored, according to Gern et
al. [13], with points presented in parentheses: fever (>38°C)
(1); cough, mild (1), moderate (2), severe (3); rhinorrhoea,
mild (1), moderate to severe (2); hoarseness (1); duration of
illness >4 days (1); apnoea (3); wheezing (5); retractions
(5); tachypnoea (5); cyanosis (5). Mild, moderate and
severe infection were defined as sum scores 0–4, 5–10 and
11 and higher, respectively. Specially trained clinical staff
obtained paired NS and NPA.
Collection of specimens
The NPA was obtained by the use of an infant mucus
extractor (Vygon). Both nostrils were suctioned. In addi-
tion, an NS was collected; samples were collected from one
nostril and one from the hard palate using separate cotton-
tipped swabs (Infant Mucus Extractor, Vygon Pharmaceu-
tiques, Ecouen, France). The two swabs were then inserted
into one vial containing 2 ml of virus transport medium
(Gly medium).
Real-time PCR
Semi-quantitative real-time PCR was conducted on both the
NS and NPA for respiratory syncytial virus (RSV),
rhinovirus, human metapneumovirus, adenovirus, corona-
virus, influenza, parainfluenza virus (type 1, 3), para-
influenza (type 2, 4), bocavirus, Mycoplasma pneumoniae
and Chlamydia pneumoniae. Nucleic acids were extracted
using the QIAamp DSP virus kit (QIAGEN, Valencia, CA,
USA). Each sample was eluted in 200 μl buffer. cDNAwas
synthesised by using MultiScribe reverse transcriptase (RT)
and random hexamers (both from Applied Biosystems,
Foster City, CA, USA) [14]. Each 100-μl reaction mixture
contained 60 μl cDNA mix and 40 μl of eluted RNA. After
incubation for 10 min at 25°C, RT was carried out for
30 min at 48°C, followed by RT inactivation for 5 min at
95°C [14]. Samples were assayed in a 50-μl reaction
mixture containing 20 μl (c)DNA and a 30-μl mix of the
forward and reverse primers and probes. All samples had
been spiked before extraction with an internal control virus
(murine encephalomyocarditis virus [RNA] and phocine
herpes virus [DNA]). The amplification and detection were
performed by the use of an ABI Prism 7700 sequence-
detection system; 2 min at 50°C to acquire optimal
AmpErase UNG activity and 10 min at 95°C to activate
AmpliTaq Gold DNA polymerase, followed by 45 cycles of
15 s at 95°C and 1 min at 60°C [15]. Primers and probes for
the real-time PCR detection of RSV, influenza virus,
parainfluenza virus and adenovirus are available from van
de Pol et al. [16] and real-time PCR assays were performed
as described previously [17–19].
Statistical analysis
Similar to previous studies, a consensus standard was used
to assess the sensitivity of each testing method: a positive
result in either the NPA or NS was considered as the gold
standard for the presence of a pathogen and was used to
calculate the sensitivity of the NPA and NS for the
detection of the respiratory pathogens. The Chi-square test
was used and a logistic regression analysis was performed.
The outcome variable was defined as the sample being
positive. Variables used in the model were age, gender,
symptom score and multiple virus detection. Statistical
significance was concluded if the p-value was <0.05. The
statistical analyses were performed in STATA 10.0 (Stata-
Corp LP, College Station, TX, USA).
Results
A total of 163 respiratory pathogens were identified in 94
children. The majority of children (73.5%) were ill for less
than 4 days at the time of sampling. The median age at
primary infection was 104 days (range 33–269) and the
median score of symptoms was 3, indicating a mild illness
(Table 1). In all children with an illness of 5 days or longer,
one or more pathogens were detected.
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Multiple pathogens in half of the children
In 49 children (50%), one pathogen was detected: 29
rhinovirus, 11 RSV, four coronavirus, two hMPV, two
parainfluenza virus type 2 and 4, and one bocavirus. In
25 children, two pathogens were detected, of which 24
(96%) were rhinovirus with RSV. In 20 children, more
than two pathogens were detected during the first
episode of respiratory symptoms (three pathogens: n=
17; four pathogens: n=2; five pathogens: n=1). Co-
infection rates by pathogen were: rhinovirus (57%),
hMPV (60%), RSV (72%), coronavirus (71%) and
bocavirus (91%).
Sensitivity of nasal swab is lower than the aspirate for RSV
and rhinovirus
Rhinovirus was found the most frequently (n=67), fol-
lowed by RSV (n=39) and coronavirus (n=14) (Table 2).
No influenza viruses or parainfluenza type 1 and 3 viruses
were detected. The sensitivity for detecting any pathogen of
the NPA was 92% (CI95% 86.7–95.7), whereas the
sensitivity of the NS was lower at 67% (CI95% 59.1–
74.0). For the detection of RSV and rhinovirus, the
sensitivity of the NS was lower than the NPA (Table 2).
Sensitivity of nasal swab depends on viral load
The sensitivity values of the NPA and NS were investigated
in more detail for rhinovirus and RSV (Table 3). For
children with a low symptom score, the sensitivity of the
NS was lower than the NPA. The NS had a lower
sensitivity than the NPA for the 30–40 cycle threshold
(CT) values. To assess whether the sensitivity of the NS
differed by age group, gender, multiple pathogens, symp-
tom score and CT value, Chi-squared tests were performed.
The sensitivity of the NS for the detection of RSV was
related to the symptom score (p=0.001) and the sensitivity
Table 1 Characteristics of infants during the first airway infection
Characteristics All infants (N=98) Rhinovirus detected (n=67) RSV detected (n=39)
Median age in days (range) 104 (33–269) 99 (33–269) 115 (51–269)
Median days of illness at time sampling (range) 3.5 (2–31)c 4 (2–16) 4 (2–12)
% male 58% 60% 62%
Symptoms
Rhinorrhoea
None 15% 15% 18%
Mild 55% 58% 46%
Moderate–severe 30% 27% 36%
Cough
None 17% 18% 5%
Mild 36% 46% 28%
Moderate 37% 30% 46%
Severe 10% 6% 21%
Wheezinga 8% 6% 10%
Fever >38°C 17% 12% 23%
Hoarseness 28% 22% 31%
Apnoeab 3% 2% 5%
Cyanosis 1% 0% 3%
Retractions 6% 3% 5%
Tachypnoea 20% 16% 28%
Median sum score (range) 3 (0–25) 3 (0–15) 4 (1–25)
0–4 64% 72% 56%
5–10 25% 22% 26%
>10 11% 6% 18%
The values represent percentages, unless indicated otherwise
a Reported by parents
bN=97
c Duration of illness: IQR=3–5
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of the NS was related to the CT values for both RSV and
rhinovirus (p<0.001).
In the logistic regression analysis, age and gender did
not significantly predict the detection of RSVor rhinovirus.
The symptom score predicted RSV detection in both the
NPA (odds ratio [OR]: 1.21; CI95% 1.07–1.39) and the NS
(OR: 1.28; CI95% 1.12–1.48), while an inverse relationship
was observed for symptom score and rhinovirus detection
in the two samples (OR: 0.87; CI95% 0.78–0.98). The
presence of more than one pathogen predicted RSV (OR:
8.98; CI95% 3.03–26.7) or rhinovirus detection (OR: 3.66
CI95% 1.33–10.08) in the NPA. When the same analysis
was performed as a backwards regression with p<0.2, the
results did not change.
Discussion
This study illustrates that the proportion of infants where a
respiratory pathogen is detected was high (96%) and co-
infections were common. In 20 children, more than two
pathogens were detected during the first episode of respiratory
symptoms. Co-infections were observed frequently for RSV
(72%), coronavirus (71%) and bocavirus (91%) in particular.
High rates of co-infection in young children have been
described recently for childhood pneumonia, in particular, in
children aged less than 12 months [20] and in children
hospitalised with acute respiratory tract infection [21, 22].
The most frequently detected virus was RSV, followed by
human bocavirus and rhinovirus [21, 23]. A common
combination has been reported to be RSV and bocavirus
[21]. Even though a high occurrence of co-infections has
been reported, ranging from 14–16% [21, 22] to 27% [20],
our study presents an even higher rate of co-infection. A
possible explanation for this high co-infection rate may be
related to the sampling of both nostrils for the NPA. Human
bocavirus is a newly identified virus and has been detected in
respiratory tract secretions in patients with acute respiratory
symptoms in 2 to 19% of the samples [24]. Co-infection with
another virus has been observed in 40% of bocavirus-
positive children [25]. The frequent associations of bocavirus
with other respiratory viruses might be explained by the
persistence of bocavirus in the respiratory tract [25].
Furthermore, we investigated the sensitivity of the NPA
and NS tested by a real-time PCR method. The sensitivity of
the NPAwas 92%, while for the NS, it was 67%. In particular
for the detection of rhinovirus and RSV, the NS had a lower
sensitivity (75% and 51%, respectively) compared to the
NPA (97% and 100%, respectively). The sensitivity of the NS
for RSV was 100% for children with high symptom scores.
For both RSV and rhinovirus, viral load, indicated by the CT
value, was the major determinant of the sensitivity of the NS
in a dose-dependent fashion. The symptom score predicted
RSV detection in both the NPA and the NS, while an inverse
relationship was observed for symptom score and rhinovirus
detection in the two samples.
The use of a swab has been considered as a suitable
replacement in community-based research or epidemiolog-
ical studies. The major advantage of a swab is that
collection is less painful and more convenient than an
aspirate, as no additional devices are needed [5]. These
factors may outweigh some reduction in sensitivity. The
advantage of molecular methods in the detection of
respiratory viruses has been reported [26, 27] and Lambert
et al. reported that using these methods seemed to
overcome the previously observed sensitivity reduction
when less invasive specimens were combined with the
conventional laboratory methods [7]. With the recently
Table 2 Detection of respiratory pathogens and the sensitivity by sampling method
Respiratory pathogen NPA (n) NS (n) Total NPA NS
Sensitivity 95% CI* Sensitivity 95% CI*
Rhinovirus 65 50 67 97% 89.6–99.6 75% 62.5–84.4
RSV 39 20 39 100% 91.0–100 51% 34.8–67.6
Coronavirus 13 10 14 93% 66.1–99.8 71% 41.9–91.6
Bocavirus 8 7 11 73% 39.0–94.0 64% 30.8–89.1
Adenovirus 9 6 11 82% 48.2–97.7 55% 23.4–83.3
Parainfluenza type 2 and 4 9 9 11 82% 48.2–97.7 82% 48.2–97.7
hMPV 4 3 5 80% 28.4–99.5 60% 14.7–94.7
Mycoplasma pneumoniae 2 2 3 67% 9.4–99.2 67% 9.4–99.2
Chlamydia pneumoniae 1 2 2 50% 1.2–98.7 100% 15.8–100
Total 150 109 163 92% 86.7–95.7 67% 59.1–74.0
NPA: nasopharyngeal aspirate; NS: nasal swab; RSV: respiratory syncytial virus; hMPV: human metapneumovirus; CI: confidence interval
*A one-sided 97.5% confidence interval was used in case the sensitivity was 100%
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developed flocked swabs, the sensitivity is even further
improved and the flocked swabs have the advantage of
being rapid and less traumatic for paediatric patients [28].
However, the sensitivity of the flocked swab in outpatient
respiratory tract infections may be lower than in hospital-
ised patients. Further studies are required considering
different types of swabs and patient populations, and
should test for a broad spectrum of respiratory pathogens.
Our findings demonstrated a lower sensitivity of the NS,
in particular for RSV. Similar results were reported in other
studies where conventional, non-amplification-based meth-
ods were used [8, 9]. Lambert et al. did not test for
rhinovirus and this was the most frequently detected virus
in our study and elsewhere [11, 29]. No influenza
detections were found in our study. This is not explained
by sampling bias, because most swabs were taken during
Table 3 Sensitivity of the NPA and NS for the detection of rhinovirus and RSV presented by age group, gender, symptom score, presence of
multiple pathogens and CT-value of the NPA
Respiratory pathogen subgroups NPA NTS Total NPA NS
(n) (n) Sensitivity 95% CIa Sensitivity 95% CIa
Rhinovirus
Age 1–3 months 28 24 28 100% 87.7–100 86% 67.3–96.0
3–6 months 30 22 32 94% 79.2–99.2 69% 50.0–83.9
6–12 months 7 4 7 100% 59.0–100 57% 18.4–90.1
Gender Boy 38 32 40 95% 83.1–99.4 80% 64.4–90.0
Girl 27 18 27 100% 82.1–100 67% 46.0–83.5
Symptom score 0 to 4 46 36 48 96% 85.7–99.5 75% 60.4–86.4
5 to 10 15 11 15 100% 78.2–100 73% 44.9–92.2
over 11 4 3 4 100% 39.8–100 75% 19.4–99.4
Multiple pathogen No 29 25 29 100% 88.1–100 86% 68.3–96.1
Yes 36 25 38 95% 82.3–99.4 66% 48.7–80.4
CT NPAb 0–20 3 3 3 100% 29.2–100 100% 29.2–100
20–25 22 22 22 100% 84.6–100 100% 84.6–100
25–30 17 15 17 100% 80.4–100 88% 63.6–98.5
30–35 10 6 10 100% 69.2–100 60% 26.2–87.8
35–40 10 2 10 100% 69.2–100 20% 2.5–55.6
40–45 3 0 3 100% 2.9–100 0% 0–70.8
RSV
Age 1–3 months 12 7 12 100% 73.5–100 58% 27.7–84.8
3–6 months 20 11 20 100% 82.3–100 55% 31.5–77.0
6–12 months 7 2 7 100% 59.0–100 29% 7.6–64.8
Gender Boy 24 11 24 100% 85.8–100 46% 25.6–67.2
Girl 15 9 15 100% 78.2–100 60% 32.3–83.4
Symptom score 0 to 4 22 8 22 100% 84.6–100 36% 17.2–59.3
5 to 10 10 5 10 100% 69.2–100 50% 18.7–81.3
over 11 7 7 7 100% 59.0–100 100% 59.0–100
Multiple pathogen No 11 10 11 100% 71.5–100 91% 58.7–99.8
Yes 28 10 28 100% 87.7–100 36% 18.6–56.0
CT NPAb 0–20 4 4 4 100% 39.8–100 100% 39.8–100
20–25 11 10 11 100% 71.5–100 91% 58.7–99.8
25–30 4 4 4 100% 39.8–100 100% 39.8–100
30–35 7 1 7 100% 59.0–100 14% 0.4–57.9
35–40 10 0 10 100% 69.2–100 0% 0–30.8
40–45 3 1 3 100% 29.2–100 33% 0.8–90.6
NPA nasopharyngeal aspirate; NS nasal swab; RSV respiratory syncytial virus; CT Cycle threshold value
a One-sided 97.5% confidence interval was used in case sensitivity was 100%
b The CT-value of the NPA was used as a reference to compare with NS, therefore the sensitivity of the NPA is 100% for all categories
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the winter season, during which both RSV and influenza
had their peak incidence. A possible reason may be related
to the patient population and the small population size.
Another study showed similar results, with rhinovirus and
RSV being the most frequently detected [29].
There were a number of limitations of this study. Firstly,
one limitation was the timing of sampling. For five cases,
sampling occurred 10 days after the onset of illness. Since
the viral shedding of RSV is highest between days 0 and 6,
sampling should preferably occur in this period [30]. The
high proportion of positive samples, however, indicates that
this effect was not a major drawback of this study.
Secondly, in this study, pain and discomfort of the
collection of the samples was not assessed, but other
studies provided reference to this [5]. Finally, it is unknown
whether the order of obtaining the specimens may have
resulted in a lower detection rate in the NS. It is possible
that, by suctioning both nostrils for the NPA, the secretions
with virus or viral nucleic acids were reduced. This
corresponds with the finding that few mild cases were
detected with the NS, as the sensitivity of the NS dropped
with lower symptoms score and higher CT values. Because
the order and nature of the sample collection was slightly
different from the study performed by Lambert et al., the
sensitivity of the NS may be an underestimate, and caution
needs to be taken when interpreting the NS sensitivity.
RSV and rhinovirus were commonly detected in infants
during primary respiratory infection, and co-infections
occurred in about half of the children. The sensitivity of
the NPA was higher than the NS, in particular for the
detection of RSV and rhinovirus. Although the sensitivity
of a method is important, one must also take into account
the advantages that different sampling methods offer. The
great advantage of the NS is that this method can be
performed in outpatient settings without needing special
devices, is less costly and causes less distress for the patient
than the NPA. Although there is a reduction in sensitivity
for RSV, particularly in infants with mild symptoms, the NS
is convenient for sampling patients in community studies
and can be used for surveillance purposes.
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